期刊文献+

乳腺癌患者CerbB-2表达和组织激素受体、淋巴结转移的关系 被引量:4

Relationship between the express of CerbB-2 and estrogen receptor,progesterone receptor,lymph node metastasis in breast cancer
下载PDF
导出
摘要 目的探讨乳腺癌患者CerbB-2的表达情况及其与雌激素受体(ER)、孕激素受体(PR)、淋巴结转移及患者年龄的关系。方法回顾分析675例乳腺癌患者ER、PR及CerbB-2的表达情况,分析CerbB-2表达与ER、PR表达及与淋巴结转移的关系。结果CerbB-2过表达者比CerbB-2低表达者ER阳性率低(45.92%vs70.40%,P<0.01),PR阳性率低(62.24%vs73.3%,P<0.01),腋窝淋巴结转移率高(45.35%vs43.46%,P<0.01);CerbB-2过表达患者中70岁及以上者比例低于CerbB-2低表达患者(1.02%vs7.37%,P<0.05)。结论CerbB-2过表达的乳腺癌患者ER、PR表达率更低,淋巴结转移率更高,侵袭性更强,预后更差。 Objective To explore the relationship between the expression of CerbB-2 and estrogen receptor (ER), progesterone receptor (PR), lymph node metastasis in breast Cancer. Methods The clinical and pathology data from 675 breast neoplasms of women aged from 25 to 79 years were analyzed retrospectively according to the relationship between the expression of CerbB-2 and ER,PR,lymph node metastasis and age. Results In the group of tumor tissue with CerbB-2 overexpressed,the positive rates of ER was lower than that of the other group(P 〈 0. 01 ), the positive rate of PR was lower than that of the other group (P 〈 0. 01 ), The rate of lymph node metastasis was higher than that of the other group(P 〈 0.01 ), the rate of people aged more than 70 years was lower than that of the other group (P 〈 0.05 ). Conclusion Breast cancer patient with CerbB-2 overexpressed has lower expression of ER, PR, higher rate of lymph node metastasis and bad prognostic profile.
出处 《现代医学》 2009年第5期336-338,共3页 Modern Medical Journal
关键词 乳腺肿瘤 淋巴结转移 雌激素受体 孕激素受体 CERBB-2 breast cancer lymph node metastasis estrogen receptor progesterone receptor CerbB-2
  • 相关文献

参考文献7

二级参考文献50

  • 1胡勇,饶慧蓉.癌基因c-erbB-2在乳腺癌研究中的进展[J].临床与实验病理学杂志,1993,9(4):298-301. 被引量:23
  • 2王中华,徐兵河.129例30岁以下女性乳腺癌的临床特点及预后分析[J].中华肿瘤杂志,2005,27(2):111-113. 被引量:40
  • 3刘尚廉.乳腺癌雌激素受体的酶联雌二醇组化检测法[J].肿瘤,1986,6:104-104.
  • 4Kamb A, Gruis NA, Weaver F. A cell cycle regulator potentially involved in genesis of many tumor types. Science , 1994,264:436-441.
  • 5Quesnel B, Fenanx P, Phippe N ,et al. Analysis of p16 gene detection and point mutation in breast carcinoma. Br J Cancer, 1995,72:555-557.
  • 6Levine AJ, Momand J, Finlay CA, et al. The p53 tumor susspression gene. Nature , 1991, 351: 453-456.
  • 7Schmitt FC, Leal C, Lopes C. P53 protein expression and nuclear DNA content in breast introductal proliferation. J Patho, 1995,176:233-237.
  • 8Lawson JS,Field AS,Tran DD,et al.Breast cancer incidence and estrogen receptor alpha in normal mammary tissue-an epidemiologic study among Japanese women in Japan and Hawaii.Int J Cancer,2002,97(5):685-687
  • 9Norberg T,Klaar S,Karf G,et al.Imcreased p53 nutation frequency during tumor progression-results from a breast cancer cohort.Cancer Res,2001,61(22):8317-8321
  • 10Jukkola A,Bloigu R,Soini Y,et al.c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease.Eur J Cancer,2001,37(3):347-354

共引文献98

同被引文献55

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部